GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellCura ASA (FRA:C6L) » Definitions » COGS-to-Revenue

CellCura ASA (FRA:C6L) COGS-to-Revenue : 2.16 (As of Jun. 2014)


View and export this data going back to . Start your Free Trial

What is CellCura ASA COGS-to-Revenue?

CellCura ASA's Cost of Goods Sold for the three months ended in Jun. 2014 was €0.11 Mil. Its Revenue for the three months ended in Jun. 2014 was €0.05 Mil.

CellCura ASA's COGS to Revenue for the three months ended in Jun. 2014 was 2.16.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. CellCura ASA's Gross Margin % for the three months ended in Jun. 2014 was -116.33%.


CellCura ASA COGS-to-Revenue Historical Data

The historical data trend for CellCura ASA's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellCura ASA COGS-to-Revenue Chart

CellCura ASA Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
COGS-to-Revenue
Get a 7-Day Free Trial - 0.78 0.54 0.73 0.54

CellCura ASA Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 0.48 -1.28 0.42 2.16

CellCura ASA COGS-to-Revenue Calculation

CellCura ASA's COGS to Revenue for the fiscal year that ended in Dec. 2013 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.281 / 0.518
=0.54

CellCura ASA's COGS to Revenue for the quarter that ended in Jun. 2014 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.106 / 0.049
=2.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellCura ASA  (FRA:C6L) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

CellCura ASA's Gross Margin % for the three months ended in Jun. 2014 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.106 / 0.049
=-116.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


CellCura ASA COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of CellCura ASA's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CellCura ASA (FRA:C6L) Business Description

Traded in Other Exchanges
N/A
Address
Unionsgata 18, Skien, NOR, 3732
CellCura ASA is engaged in the development of novel equipment & products for use in Assisted Reproductive Technology & Stem Cell Research globally. The company also offers software solutions used in ART lab for securing the storage & management of data.

CellCura ASA (FRA:C6L) Headlines

No Headlines